125 related articles for article (PubMed ID: 30741357)
1. The occupational and quality of life consequences of chronic fatigue syndrome/myalgic encephalomyelitis in young people.
Taylor RR; O'Brien J; Kielhofner G; Lee SW; Katz B; Mears C
Br J Occup Ther; 2010 Nov; 73(11):524-530. PubMed ID: 22102767
[TBL] [Abstract][Full Text] [Related]
2. The Lonely, Isolating, and Alienating Implications of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Boulazreg S; Rokach A
Healthcare (Basel); 2020 Oct; 8(4):. PubMed ID: 33092097
[TBL] [Abstract][Full Text] [Related]
3. Measuring substantial reductions in activity.
Schafer C; Evans M; Jason LA; So S; Brown A
J Prev Interv Community; 2015; 43(1):5-19. PubMed ID: 25584524
[TBL] [Abstract][Full Text] [Related]
4. A suffering body, hidden away from others: The experience of being long-term bedridden with severe myalgic encephalomyelitis/chronic fatigue syndrome in childhood and adolescence.
Krabbe SH; Bjorbaekmo WS; Mengshoel AM; Sveen U; Groven KS
Nurs Inq; 2024 Jan; ():e12625. PubMed ID: 38280185
[TBL] [Abstract][Full Text] [Related]
5. Learning points about myalgic encephalitis/chronic fatigue syndrome: Bridging the gap between research, clinical practice and awareness.
Wahi-Singh B
J R Coll Physicians Edinb; 2024 May; ():14782715241257968. PubMed ID: 38798182
[TBL] [Abstract][Full Text] [Related]
6. Chronic fatigue syndrome and quality of life.
Roberts D
Patient Relat Outcome Meas; 2018; 9():253-262. PubMed ID: 30123017
[TBL] [Abstract][Full Text] [Related]
7. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors.
Wirth K; Scheibenbogen C
Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal cytokine and multi-modal health data of an extremely severe ME/CFS patient with HSD reveals insights into immunopathology, and disease severity.
Jahanbani F; Sing JC; Maynard RD; Jahanbani S; Dafoe J; Dafoe W; Jones N; Wallace KJ; Rastan A; Maecker HT; Röst HL; Snyder MP; Davis RW
Front Immunol; 2024; 15():1369295. PubMed ID: 38650940
[TBL] [Abstract][Full Text] [Related]
9. Preventive Medicine via Lifestyle Medicine Implementation Practices Should Consider Individuals' Complex Psychosocial Profile.
Papadakis Z; Stamatis A; Manierre M; Boolani A
Healthcare (Basel); 2022 Dec; 10(12):. PubMed ID: 36554083
[TBL] [Abstract][Full Text] [Related]
10. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Wirth KJ; Scheibenbogen C; Paul F
J Transl Med; 2021 Nov; 19(1):471. PubMed ID: 34809664
[TBL] [Abstract][Full Text] [Related]
11. Predicting GP visits: A multinomial logistic regression investigating GP visits amongst a cohort of UK patients living with Myalgic encephalomyelitis.
Walsh RS; Denovan A; Drinkwater K; Reddington S; Dagnall N
BMC Fam Pract; 2020 Jun; 21(1):105. PubMed ID: 32522264
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis between "chronic fatigue" and "chronic fatigue syndrome".
Son CG
Integr Med Res; 2019 Jun; 8(2):89-91. PubMed ID: 31193269
[No Abstract] [Full Text] [Related]
13. Response to Commentary: 'Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, and Chronic Fatigue: Three Distinct Entities Requiring Complete Different Approaches'.
Beilharz JE; Fatt SJ; Cvejic E; Lloyd AR; Vollmer-Conna U
Curr Rheumatol Rep; 2019 Apr; 21(6):22. PubMed ID: 30955109
[No Abstract] [Full Text] [Related]
14. The Invisible Burden of Chronic Fatigue in the Community: a Narrative Review.
Fatt SJ; Cvejic E; Lloyd AR; Vollmer-Conna U; Beilharz JE
Curr Rheumatol Rep; 2019 Feb; 21(2):5. PubMed ID: 30741357
[TBL] [Abstract][Full Text] [Related]
15. Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, and Chronic Fatigue: Three Distinct Entities Requiring Complete Different Approaches.
Twisk FNM
Curr Rheumatol Rep; 2019 May; 21(6):27. PubMed ID: 31073713
[TBL] [Abstract][Full Text] [Related]
16. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
Strassheim VJ; Sunnquist M; Jason LA; Newton JL
BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
